<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3779">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04425213</url>
  </required_header>
  <id_info>
    <org_study_id>2020PI082</org_study_id>
    <nct_id>NCT04425213</nct_id>
  </id_info>
  <brief_title>Obesity and Mortality of Critically Ill Patients With COVID-19</brief_title>
  <acronym>COV-OB-ICU</acronym>
  <official_title>Obesity as a Risk Factor for Mortality of Critically Ill Patients With Coronavirus Disease 2019 (COVID-19): a Cohort Study of the First Wave in Nancy, France</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Disproportionate impact of COVID-19 in patients with obesity is now well established.&#xD;
&#xD;
      Obesity is associated with severe forms of COVID-19 and may be a risk factor of intensive&#xD;
      care unit (ICU) admission. Obesity is associated with COVID-19 related hospital death in a&#xD;
      large United Kingdom cohort study. However, there is a gap of knowledge on assessment of&#xD;
      outcomes such as severity of Acute Respiratory Distress syndrome (ARDS), duration of&#xD;
      hospitalisation and mortality in ICU. Moreover, an obesity survival paradox has been observed&#xD;
      in patients with ARDS. This raises the question whether the obesity paradox has been broken&#xD;
      by COVID-19.&#xD;
&#xD;
      The investigators aim to explore risk factors of in-ICU death for patient with COVID-19,&#xD;
      including obesity and other chronic diseases and to describe the clinical course and&#xD;
      outcomes, including the management of acute respiratory failure and other intensive care&#xD;
      management.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators aim to report ICU mortality for patients according to BMI category and to&#xD;
      describe the detailed ICU clinical course of illness :&#xD;
&#xD;
        -  Risk factors for ICU mortality : age, sex, baseline comorbidities&#xD;
&#xD;
        -  Causes of death&#xD;
&#xD;
        -  Risk factors for use of non invasive mechanical ventilation&#xD;
&#xD;
        -  Non-fatal outcomes&#xD;
&#xD;
        -  Ventilator-free days&#xD;
&#xD;
        -  ICU length of stay.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 12, 2020</start_date>
  <completion_date type="Actual">May 26, 2020</completion_date>
  <primary_completion_date type="Actual">May 25, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>through study completion, an average of 14 days</time_frame>
    <description>number of fatal cases</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Invasive mechanical ventilation</measure>
    <time_frame>through study completion, an average of 14 days</time_frame>
    <description>number of patients with invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>through study completion, an average of 21 days</time_frame>
    <description>number of fatal cases</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">250</enrollment>
  <condition>COVID</condition>
  <condition>Severe Acute Respiratory Syndrome</condition>
  <condition>Obesity</condition>
  <condition>Comorbidities and Coexisting Conditions</condition>
  <arm_group>
    <arm_group_label>Normal weight</arm_group_label>
    <description>BMI &lt; 25 kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Overweight</arm_group_label>
    <description>BMI : 25 - 29.9 kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate obesity</arm_group_label>
    <description>BMI : 30 - 39.9 kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe obesity</arm_group_label>
    <description>BMI : &gt; or = 40 kg/m2</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Critically ill patients admitted to ICUs of the University Hospital during the first Covid&#xD;
        -19 wave in Nancy, Région Grand Est, France&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients with COVID-19 pneumonia admitted to ICUs between February 27th and&#xD;
             April 18th 2020.&#xD;
&#xD;
          -  Infection confirmed by reverse transcriptase polymerase chain reaction assay or&#xD;
             radiologically by chest computed tomography scan&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No weight or height measurement available in the medical files&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier Ziegler, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU of Nancy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre hospitalo-universitaire régional de Nancy</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 28, 2020</study_first_submitted>
  <study_first_submitted_qc>June 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2020</study_first_posted>
  <last_update_submitted>June 11, 2020</last_update_submitted>
  <last_update_submitted_qc>June 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mortality</keyword>
  <keyword>Covid-19</keyword>
  <keyword>Invasive mechanical ventilation</keyword>
  <keyword>Obesity</keyword>
  <keyword>Acute Respiratory Distress syndrome</keyword>
  <keyword>Intensive Care Unit</keyword>
  <keyword>Critically ill patient</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

